Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Alessandra Tucci

32PUBLICATIONS
335CO-AUTHORS
Respiratory diseasesPredictive and prognostic markersAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Humoural immunology and immunochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

Sort by Publication Date:
|May 26, 2026
Humoral and Cellular Immune Response in Patients with Hematological Disorders After Three Doses of mRNA COVID-19 Vaccine: A Single-Center Observational Study.

|Mar 25, 2026
The predictive and prognostic role of baseline 2-[18F]FDG PET/CT volumetric and dissemination features in classical Hodgkin lymphoma.

Domenico Albano, Alessandro Re, Rosa Daffini

|Feb 27, 2026
Autologous Stem Cell Transplantation in HIV-Positive and HIV-Negative Patients with Lymphoma: A Propensity Score-Matched Comparative Analysis.

Alessandro Re, Margherita Oberti, Armando Stabile

|Jan 22, 2026
Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemia.

Michela Ansuinelli, Nadia Peragine, Maria Stefania De Propris

|Jan 21, 2026
Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study.

Anna Paola Iori, Antonio De Vivo, Eros Di Bona

|Sep 12, 2025
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial.

Emanuele Zucca, Luca Ceriani, Giovannino Ciccone

Pageof 6

Frequent Collaborators

8 joint publications

Chiara Cattaneo

5 joint publications

Andrés J M Ferreri

5 joint publications

Alessandro Re

5 joint publications

Emanuele Zucca

5 joint publications

Monica Balzarotti

5 joint publications

Domenico Albano

4 joint publications

Vittorio Ruggero Zilioli

4 joint publications

Federica Cavallo

4 joint publications

Annalisa Arcari

4 joint publications

Luca Arcaini

Frequent Collaborators

8 joint publications

Chiara Cattaneo

5 joint publications

Andrés J M Ferreri

5 joint publications

Alessandro Re

5 joint publications

Emanuele Zucca